Mahiuddin Ahmed, PhDChief Scientific Officer at Y-mAbs Therapeutics, Inc.Speaker
Profile
Mahiuddin Ahmed, PhD, is currently the CSO of Y-mAbs Therapeutics and was previously a faculty member in the Department of Pediatrics at Memorial Sloan Kettering Cancer Center. Dr. Ahmed specializes in therapeutic antibody engineering based on in silico design. He received his PhD in Biochemistry and Structural Biology from Stony Brook University and completed postdoctoral training in cancer immunotherapy at the Sloan Kettering Institute. Dr. Ahmed’s research has focused on: 1) engineering bispecific antibodies for immune cell recruitment, 2) payload delivery strategies, and 3) development of TCR-like monoclonal antibodies to target intracellular cancer antigens.